Navigation Links
Seattle-Based Marsha Rivkin Center for Ovarian Cancer Research Appoints Nancy Sclater, Executive Director
Date:4/28/2008

SEATTLE, April 28 /PRNewswire/ -- Saul Rivkin, M.D., announced today the appointment of Nancy Sclater as executive director of the Marsha Rivkin Center for Ovarian Cancer Research, a unique organization that partners with Swedish Medical Center and Fred Hutchinson Cancer Research Center.

"We are thrilled that Nancy has joined our effort to help fund and fight the battle against ovarian cancer. Her leadership will be instrumental in furthering the Center's goals and in bringing together the best scientists and research to find a cure for this deadly disease," Dr. Rivkin said.

Sclater brings a depth of experience in the nonprofit sector where she promoted health-care initiatives and supported vulnerable populations. She has over 30 years experience of connecting people to support medical research. "My vision in accepting this 'challenge' is to raise awareness about ovarian cancer and much needed funding for research," Sclater said. She joins the Marsha Rivkin Center from Pinkerton Brown, an organizational management consulting firm.

In addition, Sclater is an active community member. She is currently president-elect for the Rotary Club of Seattle's Centennial Year. She has also served as a trustee on boards for various local non-profit organizations.

"I am inspired by Dr. Rivkin's commitment and compassion. I share his belief that ovarian cancer need not be the deadly disease it is today. I am committed to helping the Center develop early detection measures and secure the necessary funds for research efforts aimed at helping save thousands of lives," Sclater said.

For more information about the Marsha Rivkin Center for Ovarian Cancer Research as well as its efforts and upcoming events, visit http://www.marsharivkin.org

About the Marsha Rivkin Center

Since its inception in 1996, the Marsha Rivkin Center for Ovarian Cancer Research has been the catalyst for national and international research efforts aimed at finding solutions to ovarian cancer. A 501(c)3 nonprofit organization, the Marsha Rivkin Center looks beyond institutional boundaries and works collaboratively to find a cure for ovarian cancer. Founded by renowned Swedish Cancer Institute medical oncologist Saul Rivkin, M.D., in memory of his wife who succumbed to ovarian cancer, the Marsha Rivkin Center is a joint effort between Swedish and Fred Hutchinson Cancer Research Center. The Center is dedicated to saving lives and reducing suffering through improved treatment, early detection and prevention of ovarian cancer. Research funding from the Marsha Rivkin Center has provided the momentum to turn ovarian cancer pilot studies into nationally funded research initiatives at first-class research institutions.


'/>"/>
SOURCE Marsha Rivkin Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Upscale Seattle-Based Skincare Clinic Expands Into California With Unique Custom Tailored Skincare Approach
2. Seattle-Based Law Firm Williams Kastner Receives Significant Defense Verdict in Trade Secret Business Litigation Case
3. Einstein honors Dr. Stanley Nathenson with Marshall S. Horwitz Faculty Prize for Research Excellence
4. Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates
5. Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications
6. Cogdell Spencer Inc. Announces the Closing of the Marshall Erdman and Associates Merger
7. Modern Healthcare Names Marshall Erdman Nations Top Design-Build Company
8. Scientists Spot Brains Free Will Center
9. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
10. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
11. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... Dr. Ronald E. Hawkins, vice president ... of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean ... Dr. Bell comes to Liberty from the Ohio University Heritage College of Osteopathic ...
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... With ProGlass ... Cut Pro X . Users have total control over position, rotation, distortion, edge softness, ... all within Final Cut Pro X. , With ProGlass Prism users are given the ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals (iaedp) ... You See” body image mannequin art competition. Selected from 15 submissions from around the ... revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. ...
(Date:2/24/2017)... Fair Lawn, NJ (PRWEB) , ... February 24, ... ... with robust marketing services, which specializes in thought leadership , media ... email marketing campaigns and services that will be powered through Act-On, an intuitive ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... Craig , M.D., Ph.D., as President and Chief Executive Officer ... 20, 2017. Dr. Craig succeeds Richard Love , interim ... company,s Board of Directors.  Dr. Craig has over 20 years ... the US and Europe . ...
(Date:2/27/2017)... N.J. and PETACH TIKVAH, Israel ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... appointments of June S. Almenoff , M.D., Ph.D., ... to its Board of Directors.  "Dr. ... executives whose appointments come at an exciting time for ...
(Date:2/27/2017)... , Feb 27, 2017 Period October – December ... Operating result amounted to SEK -16.4 (-6.4) million ... per share (-0.22) before and after dilution Cash flow from ... ... to SEK 0.4 (0.4) million Operating result amounted to SEK ...
Breaking Medicine Technology: